Gastroesophageal Junction Adenocarcinoma Clinical Trials in Fuzhou, Fujian
2 recruitingFuzhou, Fujian, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma
Gastric/Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital of Xiamen University30 enrolled1 locationNCT06415669
Recruiting
Phase 2
Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.
Gastric CancerGastroesophageal Junction Adenocarcinoma
RemeGen Co., Ltd.90 enrolled11 locationsNCT06155383